Leading the way to safer medication
 Crosscheck  Recommender

Cinnarizine

Description

Cinnarizine has been shown to be a non-competitive antagonist of the smooth muscle contractions caused by various vasoactive agents including histamine. Cinnarizine also acts on vascular smooth muscle by selectively inhibiting the calcium influx into depolarised cells, thereby reducing the availability of free Ca2+ ions for the induction and maintenance of contraction.

Medicine classification

ATC Code
Title
Class
N07CA02
Cinnarizine
N Nervous system → N07 Other nervous system drugs → N07C Antivertigo preparations → N07CA Antivertigo preparations

Medicines

Drug
Countries
ANTEROLSERAN

Hong Kong

CELENID

Singapore

CINNARON

Cyprus Singapore

STUGERON

Cyprus Lithuania Singapore Spain United Kingdom

Other medications with this active ingredient in combination: ARLEVERT AZALONUM CLINADIL PHEZAM PRIMATOUR

Product monographs

Monograph
Type
Country
STUGERON Tablet
MPI, EU: SmPC
UK

2D Molecule Structure

Unique Ingredient Identifier (UNII)

3DI2E1X18L - CINNARIZINE

CAS Registry Number

298-57-7 - cinnarizine

SNOMED-CT

395955001 - Cinnarizine (substance)

 
Next: Usage >